Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.59
-0.06-3.64%
At close: -
$1.57
-0.02-1.25%
After Hours: 4:34 PM EDT
Comments
Loading...
Metagenomi Analyst Ratings and Price Targets | NASDAQ:MGX | Benzinga
Metagenomi Inc has a consensus price target of $15.83 based on the ratings of 7 analysts. The high is $23 issued by Jefferies on March 5, 2024. The low is $6 issued by JP Morgan on May 2, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, HC Wainwright & Co., and HC Wainwright & Co. on March 18, 2025, December 10, 2024, and November 21, 2024, respectively. With an average price target of $13.67 between Wells Fargo, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 770.43% upside for Metagenomi Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
HC Wainwright & Co.
Chardan Capital
BMO Capital
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Metagenomi
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | Buy Now | 1173.8% | Wells Fargo | Yanan Zhu35% | $25 → $20 | Maintains | Overweight | Get Alert |
| 12/10/2024 | Buy Now | 791.66% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $14 | Maintains | Buy | Get Alert |
| 11/21/2024 | Buy Now | 345.83% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 11/20/2024 | Buy Now | 855.35% | Chardan Capital | Geulah Livshits45% | $15 → $15 | Maintains | Buy | Get Alert |
| 10/15/2024 | Buy Now | 345.83% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 09/06/2024 | Buy Now | 345.83% | HC Wainwright & Co. | Mitchell Kapoor44% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | 855.35% | Chardan Capital | Geulah Livshits45% | $15 → $15 | Maintains | Buy | Get Alert |
| 08/21/2024 | Buy Now | 345.83% | HC Wainwright & Co. | Mitchell Kapoor44% | $10 → $7 | Maintains | Buy | Get Alert |
| 08/19/2024 | Buy Now | 855.35% | Chardan Capital | Geulah Livshits45% | $17 → $15 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 982.73% | BMO Capital | Kostas Biliouris34% | $22 → $17 | Maintains | Outperform | Get Alert |
| 07/15/2024 | Buy Now | 536.9% | HC Wainwright & Co. | Mitchell Kapoor44% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/15/2024 | Buy Now | 536.9% | HC Wainwright & Co. | Mitchell Kapoor44% | $10 → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 536.9% | HC Wainwright & Co. | Mitchell Kapoor44% | → $10 | Initiates | → Buy | Get Alert |
| 05/02/2024 | Buy Now | 282.14% | JP Morgan | Brian Cheng37% | $16 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 03/28/2024 | Buy Now | 1237.49% | Chardan Capital | Geulah Livshits45% | $21 → $21 | Maintains | Buy | Get Alert |
| 03/05/2024 | Buy Now | 1301.18% | BMO Capital | Kostas Biliouris34% | → $22 | Initiates | → Outperform | Get Alert |
| 03/05/2024 | Buy Now | — | TD Cowen | Joseph Thome34% | — | Initiates | → Outperform | Get Alert |
| 03/05/2024 | Buy Now | 1492.26% | Wells Fargo | Yanan Zhu35% | → $25 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | 919.04% | JP Morgan | Brian Cheng37% | → $16 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | 1364.87% | Jefferies | Maury Raycroft31% | → $23 | Initiates | → Buy | Get Alert |
| 03/05/2024 | Buy Now | 1237.49% | Chardan Capital | Geulah Livshits45% | → $21 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Metagenomi (MGX) stock?
The latest price target for Metagenomi (NASDAQ:MGX) was reported by Wells Fargo on March 18, 2025. The analyst firm set a price target for $20.00 expecting MGX to rise to within 12 months (a possible 1173.80% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Metagenomi (MGX)?
The latest analyst rating for Metagenomi (NASDAQ:MGX) was provided by Wells Fargo, and Metagenomi maintained their overweight rating.
When was the last upgrade for Metagenomi (MGX)?
There is no last upgrade for Metagenomi
When was the last downgrade for Metagenomi (MGX)?
The last downgrade for Metagenomi Inc happened on May 2, 2024 when JP Morgan changed their price target from $16 to $6 for Metagenomi Inc.
When is the next analyst rating going to be posted or updated for Metagenomi (MGX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Metagenomi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Metagenomi was filed on March 18, 2025 so you should expect the next rating to be made available sometime around March 18, 2026.
Is the Analyst Rating Metagenomi (MGX) correct?
While ratings are subjective and will change, the latest Metagenomi (MGX) rating was a maintained with a price target of $25.00 to $20.00. The current price Metagenomi (MGX) is trading at is $1.57, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.